AlphaYouVSTM: Paterson Dan discloses securities transactions
By AlphaYouPublished Form 4
Paterson Dan
Reporting filer
Paterson Dan reported Grant or award in Verastem, Inc.: 106893 units of Common Stock, dated 2026-09-30. The full Form 4 contains 2 transaction entries.
- Disclosed
- Oct 2, 2026
Reported details
2 entries| Security | Owner | Date | Code | Action | Quantity | Price | Following holdings | Reporting delay | Filed terms and references |
|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Paterson Dan | 2026-09-30 | A | Grant or award | 106893 | 0.00 | 696,833 | 2 days | Filed terms
|
| Common Stock | Paterson Dan | 2026-10-01 | S | Sale | 44121 | 8.00 | 652,712 | 1 day | Filed terms
|
Common Stock
- Owner
- Paterson Dan
- Date
- 2026-09-30
- Code
- A
- Action
- Grant or award
- Quantity
- 106893
- Price
- 0.00
- Following holdings
- 696,833
- Reporting delay
- 2 days
- Filed terms and references
Filed terms
- security Title: Common Stock
- transaction Date: 2026-09-30
- deemed Execution Date:
- transaction Form Type: 4
- transaction Code: A
- equity Swap Involved: 0
- transaction Timeliness:
- transaction Shares: 106893
- id: F1
- transaction Price Per Share: 0.00
- transaction Acquired Disposed Code: D
- shares Owned Following Transaction: 696833
- direct Or Indirect Ownership: D
Common Stock
- Owner
- Paterson Dan
- Date
- 2026-10-01
- Code
- S
- Action
- Sale
- Quantity
- 44121
- Price
- 8.00
- Following holdings
- 652,712
- Reporting delay
- 1 day
- Filed terms and references
Filed terms
- security Title: Common Stock
- transaction Date: 2026-10-01
- deemed Execution Date:
- transaction Form Type: 4
- transaction Code: S
- equity Swap Involved: 0
- transaction Timeliness:
- transaction Shares: 44121
- id: F2
- transaction Price Per Share: 8.00
- transaction Acquired Disposed Code: D
- shares Owned Following Transaction: 652712
- direct Or Indirect Ownership: D
Purchases, sales, grants and option exercises are different transactions. The reported code identifies the action; it does not establish a motive.
Filing context
- Quantities and prices are shown in the units filed. No trade value is inferred from their product.
- Paterson Dan: President and CEO, Director.
- The filing reports a Rule 10b5-1 trading plan.
- F1: The reported securities were subject to a performance restricted stock units ("RSU") award that was granted on January 21, 2026. 106,893 RSUs vested on September 30, 2026, upon the Issuer's Compensation Committee of the board of directors determining the performance criteria related to certain clinical development goals had been achieved.
- F2: The sale reported on this Form 4 represents shares sold by the Reporting Person to satisfy statutory withholding requirements in connection with the vesting of RSUs.
Original sources
Prepared automatically from public filing data. Report a correction.